Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suriya Prausmüller

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
ESC Heart Failure|March 20, 2021
Neprilysin inhibition does not alter dynamic of proenkephalin-A 119-159 and pro-substance P in heart failureHenrike Arfsten, Georg Goliasch, Philipp E Bartko, et al.
European Heart Journal. Cardiovascular Imaging|July 2, 2019
Global regurgitant volume: approaching the critical mass in valvular-driven heart failurePhilipp E Bartko, Henrike Arfsten, Gregor Heitzinger, et al.
European Heart Journal. Cardiovascular Imaging|January 10, 2024
Annular remodelling predicts outcome in isolated severe tricuspid regurgitation: a registry-based echocardiographic analysisHenrike Arfsten, Andreas König, Welf Geller, et al.
British Journal of Clinical Pharmacology|June 30, 2020
Increased concentrations of bioactive adrenomedullin subsequently to angiotensin-receptor/neprilysin-inhibitor treatment in chronic systolic heart failureHenrike Arfsten, Georg Goliasch, Philipp E Bartko, et al.
Cardiovascular Diabetology|February 3, 2021
Performance of the recommended ESC/EASD cardiovascular risk stratification model in comparison to SCORE and NT-proBNP as a single biomarker for risk prediction in type 2 diabetes mellitusSuriya Prausmüller, Michael Resl, Henrike Arfsten, et al.
Journal of Personalized Medicine|November 19, 2020
An Integrated Imaging and Circulating Biomarker Approach for Secondary Tricuspid RegurgitationGeorg Spinka, Philipp E Bartko, Gregor Heitzinger, et al.
European Journal of Heart Failure|March 24, 2020
Increased resting heart rate and prognosis in treatment-naïve unselected cancer patients: results from a prospective observational studyMarkus S Anker, Maria K Frey, Georg Goliasch, et al.
European Journal of Preventive Cardiology|May 21, 2023
Obesity in heart failure with preserved ejection fraction with and without diabetes: risk factor or innocent bystander?Suriya Prausmüller, Annika Weidenhammer, Gregor Heitzinger, et al.
European Journal of Clinical Investigation|August 12, 2020
Secondary mitral regurgitation-Insights from microRNA assessmentGeorg Spinka, Philipp E Bartko, Noemi Pavo, et al.
Biomedicines|August 28, 2025
Implementation of Medical Therapy in Different Stages of Heart Failure with Reduced Ejection Fraction: An Analysis of the VIENNA-HF RegistryNoel G Panagiotides, Annika Weidenhammer, Suriya Prausmüller, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
ESC Heart Failure|March 20, 2021
Neprilysin inhibition does not alter dynamic of proenkephalin-A 119-159 and pro-substance P in heart failureHenrike Arfsten, Georg Goliasch, Philipp E Bartko, et al.
European Heart Journal. Cardiovascular Imaging|July 2, 2019
Global regurgitant volume: approaching the critical mass in valvular-driven heart failurePhilipp E Bartko, Henrike Arfsten, Gregor Heitzinger, et al.
European Heart Journal. Cardiovascular Imaging|January 10, 2024
Annular remodelling predicts outcome in isolated severe tricuspid regurgitation: a registry-based echocardiographic analysisHenrike Arfsten, Andreas König, Welf Geller, et al.
British Journal of Clinical Pharmacology|June 30, 2020
Increased concentrations of bioactive adrenomedullin subsequently to angiotensin-receptor/neprilysin-inhibitor treatment in chronic systolic heart failureHenrike Arfsten, Georg Goliasch, Philipp E Bartko, et al.
Cardiovascular Diabetology|February 3, 2021
Performance of the recommended ESC/EASD cardiovascular risk stratification model in comparison to SCORE and NT-proBNP as a single biomarker for risk prediction in type 2 diabetes mellitusSuriya Prausmüller, Michael Resl, Henrike Arfsten, et al.
Journal of Personalized Medicine|November 19, 2020
An Integrated Imaging and Circulating Biomarker Approach for Secondary Tricuspid RegurgitationGeorg Spinka, Philipp E Bartko, Gregor Heitzinger, et al.
European Journal of Heart Failure|March 24, 2020
Increased resting heart rate and prognosis in treatment-naïve unselected cancer patients: results from a prospective observational studyMarkus S Anker, Maria K Frey, Georg Goliasch, et al.
European Journal of Preventive Cardiology|May 21, 2023
Obesity in heart failure with preserved ejection fraction with and without diabetes: risk factor or innocent bystander?Suriya Prausmüller, Annika Weidenhammer, Gregor Heitzinger, et al.
European Journal of Clinical Investigation|August 12, 2020
Secondary mitral regurgitation-Insights from microRNA assessmentGeorg Spinka, Philipp E Bartko, Noemi Pavo, et al.
Biomedicines|August 28, 2025
Implementation of Medical Therapy in Different Stages of Heart Failure with Reduced Ejection Fraction: An Analysis of the VIENNA-HF RegistryNoel G Panagiotides, Annika Weidenhammer, Suriya Prausmüller, et al.
Pageof 4